A new Texas law that will provide up to $50 million to study ibogaine reflects growing government interest in psychedelic therapy research for mental health treatments.

Danone is recalling its popular YoCrunch products at retail stores nationwide after learning it could contain plastic pieces.

The Trump administration’s embrace of psychedelics has sparked both excitement as well as concern from those in the field.

A production issue raised concerns that ink printing on some cups could run when exposed to high temperatures, inspectors said.

Key Takeaways 10,000 health workers were officially laid off Monday across federal health agenciesThese cuts followed a U.S.

Key Takeaways A federal court has let West Virginia restrict the abortion pill mifepristoneMifepristone is approved by the ...

But benzathine penicillin G is the only product that’s approved and recommended to treat the sexually transmitted infection syphilis during pregnancy. If the infection is caught early, a single ...

A bankruptcy filing has terminated quality control processes, potentially affecting medication purity and effectiveness.

In polarized Washington, Ama is drawing leaders from both camps with an anti-additive menu and a vow to bar all manner of ...

The U.S. Food and Drug Administration's staff reviewers on Wednesday raised efficacy concerns over Otsuka Pharma's combination treatment for adults with post-traumatic stress disorder (PTSD), citing ...

While the U.S. government still officially considers marijuana a Schedule I drug with no accepted medical use, federal agencies are increasingly breaking with that position. In one notable example, an ...